Unicycive Therapeutics Announces Presentation at H.C. Wainwright Global Investment Conference
Sep 6, 2024
Disease Invest Information
FDA Grants Accelerated Approval to Ipsen and Genfit's Iqirvo for Liver Disease Treatment
Jun 12, 2024
GENFIT Announces Third Quarter 2023 Financial Outcomes and Update on R&D Progress
Nov 10, 2023